Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alvaro Sanchez-Guijo Benavente
Observed names:
Alvaro Sanchez-Guijo,
Álvaro Sánchez‐Guijo Benavente
Institutions:
Hospital Regional Universitario de Málaga,
Complejo Hospitalario de Jaén,
Andalusian Centre for Nanomedicine and Biotechnology,
Instituto de Investigación Biomédica de Málaga
Observed institutions:
Hospital Regional Universitario de Málaga,
Complejo Hospitalario de Jaén,
Andalusian Centre for Nanomedicine and Biotechnology,
Instituto de Investigación Biomédica de Málaga
ORCID:
0009-0009-7023-0710
Observed ORCID:
0009-0009-7023-0710
OpenAlex ID:
A5118747267
Long-term Impact of Cenobamate on Cognition in Patients with Drug-Resistant Focal Epilepsy: Outcomes from an Exploratory Real-World Study
2025
·
Teresa Ramirez-Garcia
, Pablo Cabezudo-Garcia
, et al.
·
Neurology and Therapy
·
5
PDF
Effectiveness and safety of cenobamate after conversion to monotherapy or dual therapy in real‐world clinical practice
2026
·
Álvaro Sánchez‐Guijo Benavente
, Guillermina García Martín
, et al.
·
Epileptic Disorders
·
1
Patient experience in healthcare interventions: PROM and PREM evaluation in patients with multiple sclerosis after switching administration route of natalizumab
2025
·
Cristina Fernández-Cuerva
, Aranzazu Linares-Alarcon
, et al.
·
European Journal of Hospital Pharmacy
·
1
Show more works
View as search
Works count:
3
Citation count:
7
H-index:
1
I10-index:
Year
Topic
Type